 |
| Robert Green, MD, MPH |
Robert Green, MD, MPH, of the Division of Genetics, was included in BIS Research and Insight Monk’s Top 25 Voices in Precision Medicine for his work on medical genetics and genomics. This annual list celebrates the groundbreaking efforts of an elite compendium of leaders worldwide who disrupt existing processes and products in the health care industry.
Green, a medical geneticist and physician-scientist who directs the G2P Research Program at the Brigham, Harvard Medical School and Broad Institute, led the first National Institutes of Health-funded randomized trials of genomic sequencing, disclosing genetic disease risks to apparently healthy individuals as well as infants. Having authored over 300 papers, he is striving to accelerate the worldwide implementation of medical genomics. In addition to his work at the Brigham, he serves as associate director for Research at Partners HealthCare’s Center for Personalized Genetic Medicine.
BIS Research is a leading global market intelligence, research, and advisory company that focuses on the emerging trends in technology that are likely to disrupt the dynamics of the market. Insight Monk helps businesses and individuals accelerate technology discovery, business evaluation and innovation planning.
